HealthTech Capital

What HealthTech Capital does

HealthTech Capital is a private membership-based investment organization founded in 2010 in Los Altos Hills, California by Anne DeGheest, a healthcare executive credited with pioneering the HealthTech/Digital Health category. The organization aggregates accredited angel investors, healthcare systems, venture capital firms, and corporate investors into a curated network that funds and mentors early-stage (seed and Series A) HealthTech startups. Its core "product" is the Membership program, which provides deal flow access, a monthly screening process (4 companies per dinner, third Tuesday of each month, now conducted virtually since COVID-19), due diligence infrastructure, and syndication opportunities. The portfolio includes companies such as Omada Health, Wildflower Health, Avive, Bloomlife, CarePredict, Infobionic, CloudCath, and Holobiome, with notable exits including Liftware (acquired by Google/Verily), Tueo Health (acquired by Apple), and CareInSync (acquired by Hearst); portfolio companies have collectively raised over $1 billion in follow-on capital from leading venture and corporate investors.

HealthTech Capital's business model rests on two revenue streams: (1) annual corporate membership dues across Bronze, Silver, and Gold tiers, which provide access to deal flow, mentoring, and internal round tables, and (2) sweat-equity or vesting-option compensation from portfolio companies for customized mentoring services. Entrepreneurs are not charged to apply or present. Add-on services include the Launchpad Program — a selective bundled package (1-3 companies per year, 3-month virtual engagement) offering market fit assessment, fundraising support, pitch coaching, regulatory and reimbursement strategy, and product development guidance — and the Analyst-in-Residence (AiR) educational program that supplies operational capacity in exchange for training. Corporate members span major healthcare stakeholders (Philips Ventures, Roche Diagnostics, Merck Global Health Innovation, AbbVie, Genentech, Humana, ResMed, California Healthcare Foundation, University of Vermont Health Network), giving portfolio companies direct channel access to payers, providers, medical device makers, and pharmaceutical firms.

Technology is not a differentiator. The organization runs its deal pipeline on the Dealum platform (adopted July 2022) and uses Proseeder internally for deal rating; the website and member portal are standard GoDaddy-built web properties. Distribution is entirely community-led and event-driven: deal submissions arrive through the online portal and referrals from a network that includes the Angel Capital Association (14,000 angels across 275 groups), with outreach reinforced through conference attendance, podcast appearances, and a blog. HealthTech Capital is not a venture fund with a finite life; it is a durable, founder-led angel syndicate whose value proposition is concentrated almost entirely in Anne DeGheest's reputation, relationships, and the multi-sided corporate/angel network she has cultivated.

Name

HealthTech Capital

Legal name

HealthTech Capital

Website

https://healthtechcapital.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

101–250 employees

Short description

HealthTech Capital is a private membership-based angel investment organization founded in 2010 that aggregates accredited investors and healthcare corporates to fund and mentor seed and Series A HealthTech startups, generating returns through equity investments and corporate membership dues.

Ownership category

akta.pro rank

Product category

Angel Investment Network

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

akta.pro secondary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Angel investing network
• Healthtech venture capital
• Startup mentoring services
• Membership investment group
• Seed series A funding

Headquarters

HQ city

Los Altos Hills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Investment Returns: HealthTech Capital generates returns through equity investments in HealthTech startups at seed and Series A stages. Compensation for mentoring services is expected in the form of common stock grant or vesting options over the first 12 months.
2. Membership Dues: Corporate membership levels (Bronze, Silver, Gold) provide annual membership access to deal flow, industry connections, and mentoring programs. Angel membership is by invitation for accredited investors.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

HealthTech Capital operates a membership-based angel investment organization that funds and mentors early-stage HealthTech startups at the seed and Series A stages. Members include accredited angel investors, healthcare systems, venture and corporate investors, with startups gaining access to capital, hands-on mentoring, corporate partnerships, and pitch coaching through a monthly screening and due diligence process.

Product overview

HealthTech Capital is a membership-based investment organization founded in 2010, comprised of angel investors, healthcare executives, and corporate venture groups. The core offering is the Membership program, which provides access to deal flow, screening meetings, and due diligence processes for HealthTech startups. This is supported by specialized add-on programs including the Launchpad Program (a bundled 3-month virtual mentoring and investment package selecting only 1-3 companies annually) and Customized Mentoring services with equity compensation. The company also operates an Analyst-in-Residence educational program, organizes HealthTech Conferences (2012-2015), and produces a podcast series. The Startup Screening Process serves as the primary mechanism for evaluating investment opportunities through monthly video presentations and structured feedback.

Differentiator

Problem solved

Functional benefit

Products and services

• HealthTech Capital Membership A membership organization for accredited angel investors, healthcare systems, venture and corporate investors that provides access to deal flow, monthly screening meetings, due diligence processes, and investor network syndication for early-stage HealthTech companies.
• Launchpad Program A bundled 3-month virtual program offering sweat equity and preferred note investment combined with customized mentoring including market fit assessment, fundraising support, pitch coaching, industry network access, regulatory and reimbursement strategy, and product development assistance. Selects 1-3 companies per year.
• Customized Mentoring Strategic advisory services provided by experienced mentors who serve as technical service providers, strategic advisors, board members, or board observers. Compensation is typically in the form of common stock grant or vesting options over the first 12 months.
• Analyst-in-Residence (AiR) Program An educational program for post-graduate professionals who volunteer their time to help with HTC operations and research in exchange for learning about early-stage investing, due diligence, and portfolio management, plus access to the member network.

Quantifiable outcome

• Over $1 Billion follow-on capital raised by portfolio companies
• +4 more outcomes

Named customers15 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Angel Capital AssociationcoreStrategic or Co-development PartnerHealthTech Capital is a member of the Angel Capital Association which represents 14,000 angels from 275 angel groups, enabling syndication and access to additional quality vetted deals across the US.
• DealumcoreTechnology or IntegrationTechnology platform partner powering the online submission portal and membership portal since July 2022, providing better experience for entrepreneurs and enabling syndication with other investor groups.

Scale indicators6 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Life Science Angels: Membership-based angel investor organization focused exclusively on early-stage healthcare and life sciences companies. Closest structural analogue to HealthTech Capital, with a screening committee, monthly pitch meetings, and member dues model.
• Keiretsu Forum: Large multi-chapter angel network with a dedicated HealthTech/HealthCare track and similar monthly screening and due diligence processes. Comparable in syndication-driven funding of early-stage companies.
• Band of Angels: Silicon Valley-based angel group that invests across healthcare, technology, and cleantech through a structured screening process. Comparable membership-driven model and broad sector coverage with some health deals.

Emerging players

• Wavemaker Three-Sixty Health: Early-stage fund focused on U.S. digital health, healthcare IT, and tech-enabled services, with explicit sector focus similar to HTC. Comparable vertical-specialist investment thesis but as a fund rather than a membership angel group.
• Jumpstart Health Investors: Healthcare-focused early-stage investment platform that aggregates multiple funds to invest in seed and Series A healthtech and digital health companies. Comparable vertical focus and seed-to-Series A entry strategy.
• Excelestar Ventures: Venture group investing in early-stage digital health and healthtech, with an emphasis on hands-on mentoring. Comparable in combining capital with operational support to healthcare founders.

Broad incumbents

• Sandbox Industries: Operator of the BlueCross BlueShield Venture Fund and Elevate Ventures, investing in early- and growth-stage healthcare and insurtech. Comparable healthcare vertical focus but operates a traditional fund model.
• Mass General Brigham Ventures: Hospital-affiliated corporate venture arm investing in digital health, medtech, and therapeutics from proof-of-concept through Series A/B. Comparable provider-side vantage point and U.S. focus.

Regional players

• Boston Harbor Angels: East Coast membership-based angel group with active healthtech and life sciences screening committees. Same membership/screening structure as HTC but focused on the Boston/Northeast innovation ecosystem.

Others

• California Health Care Foundation Innovation Fund: Program-related investment vehicle making equity investments in healthcare innovation. HTC member (Carl Bouthillette has served on its Innovation Fund) and a financing partner/advisor to the digital health ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/anne-degheest-7926a1
• Xx.com/HealthTechCap
• Facebookfacebook.com/221892537834738

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments97 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthTech Capital